Literature DB >> 16896879

Distress before chemotherapy predicts delayed but not acute nausea.

Sara C Higgins1, Guy H Montgomery, Dana H Bovbjerg.   

Abstract

INTRODUCTION: Posttreatment nausea (PTN) is a common side effect of cytotoxic cancer chemotherapy. Previous retrospective research has suggested that the severity of PTN may be, in part, related to pretreatment psychological factors (e.g., emotional distress and expectations for nausea).
MATERIALS AND METHODS: The purpose of the present study was to examine these relationships prospectively, with distress and nausea expectations assessed by validated self-report measures completed in the clinic before the participants' first outpatient treatment infusion and with PTN (0-100) assessed by end-of-day diaries completed at home on each of the first 5 days after treatment. The participants were chemotherapy-naive women (N=56) scheduled for standard adjuvant treatment for stage I-II breast cancer (mean age=45.6 years). PTN was evaluated for acute (days 0-1) and delayed (days 2-5) responses.
RESULTS: The results revealed a significant relationship between pretreatment distress and the severity of the patients' subsequent delayed nausea (p<0.007) but not a relationship with acute PTN (p<0.19). No significant relationships were seen between expectations and PTN. However, there was evidence of an additive effect of nausea expectations and distress, with the highest levels of delayed PTN seen in patients with both expectations and higher distress before treatment. The results suggest a selective effect of pre-infusion psychological variables on the delayed phase of nausea after chemotherapy, consistent with an emerging view that the different phases of nausea are mediated by different neural pathways.
CONCLUSION: Future research should examine the possibility that delayed nausea, which the literature suggests is more resistant to antiemetic drugs than acute nausea, might be responsive to psychological interventions before initial treatments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896879     DOI: 10.1007/s00520-006-0113-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  34 in total

Review 1.  Chemotherapy-related nausea and vomiting - past reflections, present practice and future management.

Authors:  M Miller; N Kearney
Journal:  Eur J Cancer Care (Engl)       Date:  2004-03       Impact factor: 2.520

2.  Association of chemotherapy related nausea and vomiting with pretreatment anxiety.

Authors:  V A Rhodes; P M Watson; M H Johnson
Journal:  Oncol Nurs Forum       Date:  1986 Jan-Feb       Impact factor: 2.172

Review 3.  Nausea: the neglected symptom?

Authors:  Jan Foubert; Giel Vaessen
Journal:  Eur J Oncol Nurs       Date:  2005-03       Impact factor: 2.398

Review 4.  Central neurocircuitry associated with emesis.

Authors:  P J Hornby
Journal:  Am J Med       Date:  2001-12-03       Impact factor: 4.965

5.  The role of psychological variables in post-chemotherapy nausea: anxiety and expectation.

Authors:  M A Andrykowski; M E Gregg
Journal:  Psychosom Med       Date:  1992 Jan-Feb       Impact factor: 4.312

6.  Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients.

Authors:  A Molassiotis; B M C Yam; H Yung; F Y S Chan; T S K Mok
Journal:  Support Care Cancer       Date:  2001-11-20       Impact factor: 3.603

7.  Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.

Authors:  D Osoba; B Zee; J Pater; D Warr; J Latreille; L Kaizer
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

8.  The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.

Authors:  Paul J Hesketh; Steven M Grunberg; Richard J Gralla; David G Warr; Fausto Roila; Ronald de Wit; Sant P Chawla; Alexandra D Carides; Juliana Ianus; Mary E Elmer; Judith K Evans; Klaus Beck; Scott Reines; Kevin J Horgan
Journal:  J Clin Oncol       Date:  2003-10-14       Impact factor: 44.544

9.  Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists.

Authors:  M de Boer-Dennert; R de Wit; P I Schmitz; J Djontono; V v Beurden; G Stoter; J Verweij
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Early stage cervical cancer: psychosocial and sexual outcomes of treatment.

Authors:  A Cull; V J Cowie; D I Farquharson; J R Livingstone; G E Smart; R A Elton
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

View more
  7 in total

1.  Effect of pretreatment distress on daily fatigue after chemotherapy for breast cancer.

Authors:  Sara C Higgins; Guy H Montgomery; George Raptis; Dana H Bovbjerg
Journal:  J Oncol Pract       Date:  2008-03       Impact factor: 3.840

2.  Self-reported taste and smell changes during cancer chemotherapy.

Authors:  Britt-Marie Bernhardson; Carol Tishelman; Lars E Rutqvist
Journal:  Support Care Cancer       Date:  2007-08-21       Impact factor: 3.603

Review 3.  A meta-analysis of the relationship between response expectancies and cancer treatment-related side effects.

Authors:  Stephanie J Sohl; Julie B Schnur; Guy H Montgomery
Journal:  J Pain Symptom Manage       Date:  2009-09-23       Impact factor: 3.612

4.  Ethnicity and persistent symptom burden in breast cancer survivors.

Authors:  Olivia S Fu; Katherine D Crew; Judith S Jacobson; Heather Greenlee; Gary Yu; Julie Campbell; Yvette Ortiz; Dawn L Hershman
Journal:  J Cancer Surviv       Date:  2009-10-27       Impact factor: 4.442

5.  Getting the grip on nonspecific treatment effects: emesis in patients randomized to acupuncture or sham compared to patients receiving standard care.

Authors:  Anna Enblom; Mats Lekander; Mats Hammar; Anna Johnsson; Erik Onelöv; Martin Ingvar; Gunnar Steineck; Sussanne Börjeson
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

Review 6.  Integrative review of factors related to the nursing diagnosis nausea during antineoplastic chemotherapy.

Authors:  Aline Maria Bonini Moysés; Lais Corsino Durant; Ana Maria de Almeida; Thais de Oliveira Gozzo
Journal:  Rev Lat Am Enfermagem       Date:  2016-10-10

Review 7.  Delayed Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Incidence, and Current Management.

Authors:  Bernardo L Rapoport
Journal:  Front Pharmacol       Date:  2017-01-30       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.